Chia Ling Wang
Director/Board Member at UNITED BIOPHARMA INC
Chia Ling Wang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| UNITED BIOPHARMA INC | Director/Board Member | 2014-09-29 | - |
| Independent Dir/Board Member | 2014-09-29 | - | |
| SHANGHAI BAOLONG AUTOMOTIVE CORPORATION | Director/Board Member | 2013-12-31 | - |
| The Hong Kong University of Science & Technology | Corporate Officer/Principal | - | - |
Career history of Chia Ling Wang
Former positions of Chia Ling Wang
| Companies | Position | Start | End |
|---|---|---|---|
| TELEVISION BROADCASTS LIMITED | Director/Board Member | 2015-03-31 | 2021-05-25 |
| Independent Dir/Board Member | 2015-03-31 | 2021-05-25 |
Training of Chia Ling Wang
| Harvard University | Graduate Degree |
| University of Wisconsin-Milwaukee | Graduate Degree |
| National Taiwan University | Undergraduate Degree |
Statistics
International
| Taiwan | 3 |
| United States | 3 |
| Hong Kong | 3 |
Operational
| Director/Board Member | 3 |
| Independent Dir/Board Member | 2 |
| Graduate Degree | 2 |
Sectoral
| Consumer Services | 6 |
| Health Technology | 2 |
| Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| TELEVISION BROADCASTS LIMITED | Consumer Services |
| SHANGHAI BAOLONG AUTOMOTIVE CORPORATION | Producer Manufacturing |
| Private companies | 1 |
|---|---|
United BioPharma, Inc.
 United BioPharma, Inc. Pharmaceuticals: MajorHealth Technology United BioPharma, Inc. engages in the development, manufacture, and sale of monoclonal antibody drug. The company's business activities include the manufacture and sale of western drugs. Its products include trastumab, adalimumab, bevacizumab, rituximab, and omalizumab. The company was founded by Chang Yi Wang on September 30, 2013 and is headquartered in Hsinchu, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Chia Ling Wang
- Experience
